Law360, New York (October 25, 2012, 8:02 PM ET) -- An Arkansas federal judge refused Wednesday to grant a new trial to a woman who claimed Premarin and other menopause hormone therapy drugs by Pfizer Inc. units Wyeth Pharmaceuticals Inc. and Pharmacia & Upjohn Inc. gave her breast cancer.
U.S. District Judge Billy Roy Wilson upheld a jury's August verdict for Pfizer, rejecting Sondra Welch's claims over juror misconduct and that certain information that a bailiff had shared with the jurors about previous Pfizer hormone therapy drug trials had been prejudicial.
“We are pleased that the...
Pfizer Won't Face Retrial In Premarin Breast Cancer Suit
To view the full article, take a free trial now.
